Mandate

Vinge advises Nordic Paper Holding AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Nordic Paper Holding AB (publ) (“Nordic Paper” or the “Company”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 12 October 2020 and the first day of trading on Nasdaq Stockholm was 22 October 2020.

The price in the offering was SEK 43 per share, corresponding to a market capitalisation of all of Nordic Paper’s shares upon completion of the offering of approximately SEK 2,877 million. The offering comprised 34,123,488 existing shares, of which all were offered by Shanying International Holding Co., Ltd. (through Sutriv Holding AB).

Nordic Paper is a producer of specialty paper with a leading position within kraft paper and natural greaseproof paper. The Company operates through four production sites located in Säffle, Greåker, Bäckhammar and Åmotfors, which manufacture high quality pulp and paper with an annual total production capacity of 286 ktonnes paper, whereas the volume of paper sold in 2019 amounted to 264 ktonnes. Nordic Paper has approximately 700 customers located in approximately 70 countries and close to 95 per cent of the Company’s manufactured paper is exported.

Vinge’s team primarily consisted of David Andersson, Malte St Cyr Ohm, Boris Kotur, Amanda M Johansson and Emil Lindwall (Capital Markets and Public M&A), Jonas Bergström, Milad Kamali and Clara Sohlberg (M&A), Johan Cederblad and Olof Löfvenberg (Environmental law), Albert Wållgren and Pauline Lagerstrand and Felix Möller (Banking and Finance), Maria Schultzberg and Victor Ericsson (Corporate tax), Sara Strandberg (Employment and Benefits), Lisa Hörnqvist (Corporate Commercial), Mia Falk and Anders Leissner (Compliance), as well as Jessica Öijer (VDR specialist).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025